GEN Exclusives

More »

Insight & Intelligence™

Back to Item »

Opinion: Pathway for FOBs Should Balance Need for Competition and Need for Innovation

Biotech industry should support innovations including those inherent in developing biosimilars, says James Bianco, M.D., principal founder, CEO, and director of Cell Therapeutics.

Forward this item to a colleague:


 
   

(Separate multiple addresses by commas)

   

(Separate multiple addresses by commas)

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

Moral Calculations May Shift Biobank Balances

How should consent terms reconcile donors’ moral concerns with biobanks’ research goals?